Does nonmetastatic castration-resistant prostate cancer still exist?
- PMID: 29686422
- DOI: 10.1038/s41571-018-0025-z
Does nonmetastatic castration-resistant prostate cancer still exist?
Comment on
-
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.J Clin Oncol. 2005 May 1;23(13):2918-25. doi: 10.1200/JCO.2005.01.529. J Clin Oncol. 2005. PMID: 15860850 Clinical Trial.
Similar articles
-
Re: Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men with Castration-Resistant Prostate Cancer.J Urol. 2016 Sep;196(3):742. doi: 10.1016/j.juro.2016.06.067. Epub 2016 Jun 16. J Urol. 2016. PMID: 27597066 No abstract available.
-
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.Cancer. 2016 Jan 15;122(2):222-9. doi: 10.1002/cncr.29748. Epub 2015 Oct 20. Cancer. 2016. PMID: 26484853
-
The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer.Jpn J Clin Oncol. 2014 Sep;44(9):860-7. doi: 10.1093/jjco/hyu081. Epub 2014 Jun 20. Jpn J Clin Oncol. 2014. PMID: 24951829
-
Treatment of Nonmetastatic Castration-Resistant Prostate Cancer.Oncology (Williston Park). 2016 Apr;30(4):336-44. Oncology (Williston Park). 2016. PMID: 27085332 Review.
-
Apalutamide for the treatment of patients with castration-resistant prostate cancer.Drugs Today (Barc). 2018 Oct;54(10):585-590. doi: 10.1358/dot.2018.54.10.2885880. Drugs Today (Barc). 2018. PMID: 30398479 Review.
Cited by
-
A framework for the development of effective anti-metastatic agents.Nat Rev Clin Oncol. 2019 Mar;16(3):185-204. doi: 10.1038/s41571-018-0134-8. Nat Rev Clin Oncol. 2019. PMID: 30514977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical